Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$191.17 - $325.63 $62,130 - $105,829
-325 Reduced 8.34%
3,574 $1.16 Million
Q4 2023

May 16, 2024

BUY
$160.99 - $215.69 $52,321 - $70,099
325 Added 9.09%
3,899 $742,000
Q4 2023

Feb 02, 2024

SELL
$160.99 - $215.69 $12,557 - $16,823
-78 Reduced 1.96%
3,899 $743,000
Q3 2023

Nov 13, 2023

BUY
$194.33 - $283.97 $50,914 - $74,400
262 Added 7.05%
3,977 $792,000
Q2 2023

Jul 24, 2023

BUY
$223.05 - $302.68 $828,630 - $1.12 Million
3,715 New
3,715 $1.06 Million
Q1 2023

May 11, 2023

BUY
$175.41 - $217.92 $36,309 - $45,109
207 Added 5.79%
3,781 $820,000
Q4 2022

Jan 24, 2023

BUY
$204.38 - $296.82 $56,408 - $81,922
276 Added 8.37%
3,574 $735,000
Q3 2022

Nov 04, 2022

SELL
$195.21 - $310.53 $258,067 - $410,520
-1,322 Reduced 28.61%
3,298 $917,000
Q2 2022

Jul 22, 2022

BUY
$115.91 - $214.48 $535,504 - $990,897
4,620 New
4,620 $883,000
Q2 2021

Jul 23, 2021

SELL
$131.45 - $201.49 $433,784 - $664,917
-3,300 Closed
0 $0
Q1 2021

May 10, 2021

SELL
$92.73 - $142.05 $334,106 - $511,806
-3,603 Reduced 52.19%
3,300 $430,000
Q4 2020

Feb 24, 2021

BUY
$67.44 - $103.72 $98,394 - $151,327
1,459 Added 26.8%
6,903 $716,000
Q4 2020

Feb 12, 2021

BUY
$67.44 - $103.72 $146,951 - $226,005
2,179 Added 66.74%
5,444 $716,000
Q3 2020

Nov 10, 2020

SELL
$42.79 - $75.8 $724,477 - $1.28 Million
-16,931 Reduced 83.83%
3,265 $247,000
Q2 2020

Aug 12, 2020

SELL
$27.25 - $47.53 $5,967 - $10,409
-219 Reduced 1.07%
20,196 $957,000
Q1 2020

May 13, 2020

BUY
$23.16 - $47.74 $472,811 - $974,612
20,415 New
20,415 $701,000

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Bank Julius Baer & Co. Ltd, Zurich Portfolio

Follow Bank Julius Baer & Co. Ltd, Zurich and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

News

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.